Latest filing published 06 Jul 2023 for Recursion Pharmaceuticals, INC..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Zachary Bogue: trading record in brief
Zachary Bogue (board member) discloses dealings in Recursion Pharmaceuticals, Inc. to SEC (Form 4). We count 18 filings; the first trade dates from 20 April 2021 and the latest from 3 July 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 6 July 2023 came the latest disclosure, a share grant in Recursion Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Zachary Bogue
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,440 shares0Class A Common StockSEC:0001209191-23-041650:0
- 1,542 shares0Class A Common StockSEC:0001209191-23-023435:0
- 1,407 shares0Class A Common StockSEC:0001209191-23-002062:0
- 977 shares0Class A Common StockSEC:0001209191-22-052907:0
- 1,260 shares0Class A Common StockSEC:0001209191-22-041270:0
- 1,382 shares0Class A Common StockSEC:0001209191-22-023323:0
- 589 shares0Class A Common StockSEC:0001209191-22-002045:0
- 295 shares0Class A Common StockSEC:0001209191-21-059741:0
- 295 shares0Class A Common StockSEC:0001209191-21-045549:0
9 of 9 declarations
